Vertex Pharmaceuticals (VRTX) closed at $453.74 in the latest trading session, marking a -1.31% move from the prior day. This change lagged the S&P 500's daily loss of 0.14%. Meanwhile, the Dow ...

Vertex (VERX) shares have come under pressure in recent trading. The stock has seen losses of 7% over the past day and nearly 10% for the week. This has sparked questions about what might be driving ...

Investors with significant funds have taken a bearish position in Vertex Pharmaceuticals (NASDAQ:VRTX), a development that retail traders should be aware of. This was brought to our attention today ...

On Thursday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) fell 17.4% in the afternoon session after the company announced its experimental pain drug, VX-993, failed a key mid-stage clinical trial ...

Vertex VERX shares are trading higher on Wednesday after the company reported better-than-expected Q4 results. Vertex reported quarterly earnings of $0.08 per share which beat the analyst consensus ...

Despite the positive outlook, investors should note that Vertex is trading at relatively high multiples. The company's P/E ratio stands at 321.16, which corroborates the InvestingPro Tip stating that ...

With crypto trading activity picking up on Arbitrum, a new protocol called Vertex is setting its sights on the institutional clientele seeking to trade on decentralized exchanges (DEX) atop the ...

Vertex Energy Inc VTNR shares are trading higher on Tuesday after the company reported better-than-expected Q4 EPS results. Vertex Energy reported quarterly earnings of $0.56 per share which beat the ...